O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone

Authors:
  • RBRenee Bailey
    Renee Bailey
  • MKMark Kris
    Mark Kris
  • MWMichael Wolf
    Michael Wolf
  • AKAndrea Kay
    Andrea Kay
  • SASteven Averbuch
    Steven Averbuch
  • JAJon Askaa
    Jon Askaa
  • MJMette Janas
    Mette Janas
  • KSKarsten Schmidt
    Karsten Schmidt
  • MFMasahiro Fukuoka
    Masahiro Fukuoka

Abstract
No abstract available